New hope for Tough-to-Treat lymphoma: experimental combo aims to control disease
Disease control
Recruiting now
This study is testing whether adding a new drug called epcoritamab to a standard chemotherapy regimen (GDP) is safe and effective for adults whose large B-cell lymphoma has returned or stopped responding to prior treatment. The goal is to control the cancer and see if patients ca…
Phase: PHASE2 • Sponsor: Dipenkumar Modi • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC